Latest Breaking News On - Theresagh heah - Page 1 : comparemela.com

Intergalactic Therapeutics to Present Updated Data From Its Non-Viral Gene Therapy Platform at the 2023 Retinal Cell and Gene Therapy Innovation Summit

/PRNewswire/ Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today that Gayathri Ramaswamy,.

United statesUnited kingdomNew orleansGayathri ramaswamyTheresagh heahVice presidentDrug discoveryDisease biologyAnnual retinal cellGene therapy innovation summitMarriott new orleans warehouse arts districtChief executive officerApple tree partnersIntergalactic therapeutics

Intergalactic Therapeutics Announces Positive Preclinical Results of Its Non-Viral Gene Therapy Platform in ABCA4 Retinopathies

/PRNewswire/ Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today positive preclinical.

United kingdomMark pennesiTheresagh heahCasey eye instituteIntergalactic ophthalmology advisory panelChief scientific officerEye instituteOphthalmology advisoryUnique combinationChief executive officerApple tree partnersIntergalactic therapeutics

Intergalactic Therapeutics Appoints Theresa G H Heah, M D , M B A , as Chief Executive Officer

Intergalactic Therapeutics Appoints Theresa G H Heah, M D , M B A , as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCalifornia institute of technologyUnited kingdomCity ofSan franciscoMichael ehlersTheresagh heahFovea pharmaceuticalsGenetic technologies corporationCompany leadershipMaster in business administrationJohns hopkins university school of medicineEuropean school of management technologyUniversity of londonKing college

Intergalactic Therapeutics Appoints Theresa G H Heah, M D , M B A , as Chief Executive Officer

/PRNewswire/ Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today the appointment of.

United statesMichael ehlersTheresagh heahFovea pharmaceuticalsGenetic technologies corporationCompany leadershipMaster in business administrationJohns hopkins university school of medicineEuropean school of management technologyCalifornia institute of technologyUniversity of londonKing collegeThoma school of medicineAerie pharmaceuticalsChief executive officerChief scientific officer